Report Summary
Summary
Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME).
The market of macular edema is dominated by North America which is followed by Europe due tremendous number of population suffering from diabetics. Asia Pacific region have also shown faster rate of increases of macular edema therapeutics market. While Africa and Australia have low market of Macular edema. In Asia pacific region India, China and Brazil have shown emerging growth in the global market of macular edema therapeutics.
In 2020, the global Macular Edema Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% between 2021 and 2027.
This report studies the Macular Edema Therapeutics market size by players, regions, product types and end industries, history data 2017-2020 and forecast data 2021-2027; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
This report focuses on the global top players, covered
Allergan
Novartis
Roche
Regeneron Pharmaceuticals
Pfizer
Bayer
Boehringer Ingelheim
Bausch & Lomb
Aciont
ActiveSite Pharmaceuticals
Adverum Biotechnologies
Aerpio Therapeutics
Ampio Pharmaceuticals
Araim Pharmaceuticals
Astellas Pharma
Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa
Market segment by Type, the product can be split into
Laser Treatment
Anti-VEGF Injection
Anti-Inflammatory Treatment
Vitrectomy
Market segment by Application, the market can be split into
Cystoid Macular Edema (CME)
Diabetic Macular Edema(DME)
The study objectives of this report are:
To study and forecast the market size of Macular Edema Therapeutics in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Macular Edema Therapeutics are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, EternityInsights offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Macular Edema Therapeutics market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table Of Contents
Table of Contents
Macular Edema Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Macular Edema Therapeutics
1.1 Macular Edema Therapeutics Market Overview
1.1.1 Macular Edema Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Macular Edema Therapeutics Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Macular Edema Therapeutics Market by Type
1.3.1 Laser Treatment
1.3.2 Anti-VEGF Injection
1.3.3 Anti-Inflammatory Treatment
1.3.4 Vitrectomy
1.4 Macular Edema Therapeutics Market by End Users/Application
1.4.1 Cystoid Macular Edema (CME)
1.4.2 Diabetic Macular Edema(DME)
2 Global Macular Edema Therapeutics Competition Analysis by Players
2.1 Macular Edema Therapeutics Market Size (Value) by Players (2019 and 2020)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Allergan
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Macular Edema Therapeutics Revenue (Value) (2017-2020)
3.1.5 Recent Developments
3.2 Novartis
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Macular Edema Therapeutics Revenue (Value) (2017-2020)
3.2.5 Recent Developments
3.3 Roche
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Macular Edema Therapeutics Revenue (Value) (2017-2020)
3.3.5 Recent Developments
3.4 Regeneron Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Macular Edema Therapeutics Revenue (Value) (2017-2020)
3.4.5 Recent Developments
3.5 Pfizer
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Macular Edema Therapeutics Revenue (Value) (2017-2020)
3.5.5 Recent Developments
3.6 Bayer
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Macular Edema Therapeutics Revenue (Value) (2017-2020)
3.6.5 Recent Developments
3.7 Boehringer Ingelheim
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Macular Edema Therapeutics Revenue (Value) (2017-2020)
3.7.5 Recent Developments
3.8 Bausch & Lomb
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Macular Edema Therapeutics Revenue (Value) (2017-2020)
3.8.5 Recent Developments
3.9 Aciont
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Macular Edema Therapeutics Revenue (Value) (2017-2020)
3.9.5 Recent Developments
3.10 ActiveSite Pharmaceuticals
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Macular Edema Therapeutics Revenue (Value) (2017-2020)
3.10.5 Recent Developments
3.11 Adverum Biotechnologies
3.12 Aerpio Therapeutics
3.13 Ampio Pharmaceuticals
3.14 Araim Pharmaceuticals
3.15 Astellas Pharma
4 Global Macular Edema Therapeutics Market Size by Type and Application (2017-2020)
4.1 Global Macular Edema Therapeutics Market Size by Type (2017-2020)
4.2 Global Macular Edema Therapeutics Market Size by Application (2017-2020)
4.3 Potential Application of Macular Edema Therapeutics in Future
4.4 Top Consumer/End Users of Macular Edema Therapeutics
5 North America Macular Edema Therapeutics Development Status and Outlook
5.1 North America Macular Edema Therapeutics Market Size (2017-2020)
5.2 North America Macular Edema Therapeutics Market Size and Market Share by Players (2019 and 2020)
6 Europe Macular Edema Therapeutics Development Status and Outlook
6.1 Europe Macular Edema Therapeutics Market Size (2017-2020)
6.2 Europe Macular Edema Therapeutics Market Size and Market Share by Players (2019 and 2020)
7 China Macular Edema Therapeutics Development Status and Outlook
7.1 China Macular Edema Therapeutics Market Size (2017-2020)
7.2 China Macular Edema Therapeutics Market Size and Market Share by Players (2019 and 2020)
8 Rest of Asia Pacific Macular Edema Therapeutics Development Status and Outlook
8.1 Rest of Asia Pacific Macular Edema Therapeutics Market Size (2017-2020)
8.2 Rest of Asia Pacific Macular Edema Therapeutics Market Size and Market Share by Players (2019 and 2020)
9 Central & South America Macular Edema Therapeutics Development Status and Outlook
9.1 Central & South America Macular Edema Therapeutics Market Size (2017-2020)
9.2 Central & South America Macular Edema Therapeutics Market Size and Market Share by Players (2019 and 2020)
10 Middle East & Africa Macular Edema Therapeutics Development Status and Outlook
10.1 Middle East & Africa Macular Edema Therapeutics Market Size (2017-2020)
10.2 Middle East & Africa Macular Edema Therapeutics Market Size and Market Share by Players (2019 and 2020)
11 Market Forecast by Regions, Type and Application (2021-2027)
11.1 Global Macular Edema Therapeutics Market Size (Value) by Regions (2021-2027)
11.1.1 North America Macular Edema Therapeutics Revenue and Growth Rate (2021-2027)
11.1.2 Europe Macular Edema Therapeutics Revenue and Growth Rate (2021-2027)
11.1.3 China Macular Edema Therapeutics Revenue and Growth Rate (2021-2027)
11.1.4 Rest of Asia Pacific Macular Edema Therapeutics Revenue and Growth Rate (2021-2027)
11.1.5 Central & South America Macular Edema Therapeutics Revenue and Growth Rate (2021-2027)
11.1.6 Middle East & Africa Macular Edema Therapeutics Revenue and Growth Rate (2021-2027)
11.2 Global Macular Edema Therapeutics Market Size (Value) by Type (2021-2027)
11.3 Global Macular Edema Therapeutics Market Size by Application (2021-2027)
12 Macular Edema Therapeutics Market Dynamics
12.1 Macular Edema Therapeutics Market Opportunities
12.2 Macular Edema Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Macular Edema Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Macular Edema Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
